Champignon mushrooms studied for potential prostate cancer prevention

Researchers are investigating the potential anti-cancer properties of champignon mushrooms (Agaricus) in relation to prostate cancer. While the consumption of these mushrooms has long been linked to health benefits, the specific biological mechanisms have remained unclear until now.

Preclinical data and early results from an ongoing phase 2 clinical trial are evaluating the efficacy of a white button mushroom-based supplement for treating prostate adenocarcinoma. Infectious disease specialist Matteo Bassetti noted that these mushrooms contain bioactive compounds capable of regulating the immune response to cancer cells, acting as an immunomodulator to hinder tumor growth.

Scientists believe beta-glucan, a polysaccharide found in the fungal cell walls, may play a significant role in this immunomodulatory activity. However, Bassetti cautioned against purchasing unapproved mushroom extracts or supplements online, as regulated medical products are not yet available.